1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > United States Peptide Hormones Industry 2015 Market Research Report

United States Peptide Hormones Industry 2015 Market Research Report

  • December 2015
  • -
  • QY Research Group
  • -
  • 138 pages

Summary


The United States Peptide Hormones Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Peptide Hormones industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Peptide Hormones market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Peptide Hormones industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 145 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Peptide Hormones Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Peptide Hormones
1.2 Classification of Peptide Hormones
1.2.1 Follicle-stimulating Hormone and Luteinizing Hormone
1.2.2 Adrenocorticotropic Hormone
1.2.3 Growth Hormones
1.2.4 Erythropoietin
1.2.5 Insulin
1.3 Applications of Peptide Hormones
1.4 Industry Chain Structure of Peptide Hormones
1.5 Industry Overview of Peptide Hormones
1.6 Industry Policy Analysis of Peptide Hormones
1.7 Industry News Analysis of Peptide Hormones

2 Manufacturing Cost Structure Analysis of Peptide Hormones
2.1 Bill of Materials (BOM) of Peptide Hormones
2.2 BOM Price Analysis of Peptide Hormones
2.3 Labor Cost Analysis of Peptide Hormones
2.4 Depreciation Cost Analysis of Peptide Hormones
2.5 Manufacturing Cost Structure Analysis of Peptide Hormones
2.6 Manufacturing Process Analysis of Peptide Hormones
2.7 China Price, Cost and Gross of Peptide Hormones 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Peptide Hormones Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Peptide Hormones Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Peptide Hormones Key Manufacturers in 2014

4 Production Analysis of Peptide Hormones by Regions, Type, and Applications
4.1 United States Production of Peptide Hormones by Regions 2010-2015
4.2 United States Production of Peptide Hormones by Type 2010-2015
4.3 United States Sales of Peptide Hormones by Applications 2010-2015
4.4 Price Analysis of United States Peptide Hormones Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Peptide Hormones 2010-2015


5 Consumption Volume and Consumption Value Analysis of Peptide Hormones by Regions
5.1 United States Consumption Volume of Peptide Hormones by Regions 2010-2015
5.2 United States Consumption Value of Peptide Hormones by Regions 2010-2015
5.3 United States Consumption Price Analysis of Peptide Hormones by Regions 2010-2015

6 Analysis of Peptide Hormones Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Peptide Hormones 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Peptide Hormones 2014-2015
6.3 Sales Overview of Peptide Hormones 2010-2015
6.4 Supply, Consumption and Gap of Peptide Hormones 2010-2015
6.5 Import, Export and Consumption of Peptide Hormones 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Peptide Hormones 2010-2015

7 Analysis of Peptide Hormones Industry Key Manufacturers
7.1 Abbott laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott laboratories SWOT Analysis

7.2 Affymax
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Affymax SWOT Analysis

7.3 Alcon
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Alcon SWOT Analysis

7.4 Alexion Pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Alexion Pharmaceuticals SWOT Analysis

7.5 Allergan
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Allergan SWOT Analysis

7.10 Biogen
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Biogen SWOT Analysis

7.11 Biotest Pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Biotest Pharmaceuticals SWOT Analysis

7.12 Boehringer Ingelheim
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Boehringer Ingelheim SWOT Analysis

7.13 Bristol-Myers Squibb
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Bristol-Myers Squibb SWOT Analysis

7.14 Btg International
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Btg International SWOT Analysis

7.15 Cangene
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Cangene SWOT Analysis

7.16 Csl
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Csl SWOT Analysis

7.17 Dendreon
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Dendreon SWOT Analysis

7.18 Eisai
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Eisai SWOT Analysis

7.19 Eli Lilly
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Eli Lilly SWOT Analysis

7.20 Ferring Pharmaceuticals
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Ferring Pharmaceuticals SWOT Analysis

7.21 Fresenius Kabi
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Fresenius Kabi SWOT Analysis

7.22 Glaxosmithkline
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Glaxosmithkline SWOT Analysis

7.23 Grifols Biologicals
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Grifols Biologicals SWOT Analysis

7.24 Roche
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Roche SWOT Analysis

7.25 Hospira
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Hospira SWOT Analysis

7.26 Janssen-Cilag
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Janssen-Cilag SWOT Analysis

7.27 Johnson and Johnson
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Johnson and Johnson SWOT Analysis

7.28 Kamada
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Kamada SWOT Analysis

7.29 Kedrion Biopharmaceuticals
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Kedrion Biopharmaceuticals SWOT Analysis

7.30 Lundbeck
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Lundbeck SWOT Analysis

7.31 Medimmune
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Medimmune SWOT Analysis

7.32 Merck
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Merck SWOT Analysis

7.33 Mylan
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Mylan SWOT Analysis

7.34 Nabi Biopharmaceuticals
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Nabi Biopharmaceuticals SWOT Analysis

7.35 Novartis
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.35.4 Novartis SWOT Analysis

7.36 Novo nordisk
7.36.1 Company Profile
7.36.2 Product Picture and Specification
7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.36.4 Novo nordisk SWOT Analysis

7.37 Octapharma pharmazeutika produktionsges.m.b.h
7.37.1 Company Profile
7.37.2 Product Picture and Specification
7.37.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.37.4 Octapharma pharmazeutika ProduktionsgesSWOT Analysis

7.38 Omrix biopharmaceuticals
7.38.1 Company Profile
7.38.2 Product Picture and Specification
7.38.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.38.4 Omrix biopharmaceuticals SWOT Analysis

7.39 Pfizer
7.39.1 Company Profile
7.39.2 Product Picture and Specification
7.39.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.39.4 Pfizer SWOT Analysis

7.40 Protein Sciences Corporation
7.40.1 Company Profile
7.40.2 Product Picture and Specification
7.40.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.40.4 Protein Sciences Corporation SWOT Analysis

7.41 Rare disease therapeutics
7.41.1 Company Profile
7.41.2 Product Picture and Specification
7.41.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.41.4 Rare disease therapeutics SWOT Analysis

7.42 Revo Biologics
7.42.1 Company Profile
7.42.2 Product Picture and Specification
7.42.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.42.4 Revo Biologics SWOT Analysis

7.43 Sandoz
7.43.1 Company Profile
7.43.2 Product Picture and Specification
7.43.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.43.4 Sandoz SWOT Analysis

7.44 Sanofi
7.44.1 Company Profile
7.44.2 Product Picture and Specification
7.44.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.44.4 Sanofi SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Peptide Hormones Product Types
8.5 Market Share Analysis of Different Peptide Hormones Price Levels
8.6 Gross Margin Analysis of Different Peptide Hormones Applications

9 Marketing Trader or Distributor Analysis of Peptide Hormones
9.1 Marketing Channels Status of Peptide Hormones
9.2 Traders or Distributors of Peptide Hormones with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Peptide Hormones
9.4 United States Import, Export and Trade Analysis of Peptide Hormones

10 Development Trend of Peptide Hormones Industry 2016-2021
10.1 Capacity and Production Overview of Peptide Hormones 2016-2021
10.2 Production Market Share by Product Types of Peptide Hormones 2016-2021
10.3 Sales and Sales Revenue Overview of Peptide Hormones 2016-2021
10.4 United States Sales of Peptide Hormones by Applications 2016-2021
10.5 Import, Export and Consumption of Peptide Hormones 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Peptide Hormones 2016-2021

11 Industry Chain Suppliers of Peptide Hormones with Contact Information
11.1 Major Raw Materials Suppliers of Peptide Hormones with Contact Information
11.2 Manufacturing Equipment Suppliers of Peptide Hormones with Contact Information
11.3 Major Players of Peptide Hormones with Contact Information
11.4 Key Consumers of Peptide Hormones with Contact Information
11.5 Supply Chain Relationship Analysis of Peptide Hormones

12 New Project Investment Feasibility Analysis of Peptide Hormones
12.1 New Project SWOT Analysis of Peptide Hormones
12.2 New Project Investment Feasibility Analysis of Peptide Hormones

13 Conclusion of the United States Peptide Hormones Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Peptide Hormones
Table Product Specifications of Peptide Hormones
Table Classification of Peptide Hormones
Figure United States Sales Market Share of Peptide Hormones by Product Types in 2014
Table Applications of Peptide Hormones
Figure United States Sales Market Share of Peptide Hormones by Applications in 2014
Figure Industry Chain Structure of Peptide Hormones
Table United States Industry Overview of Peptide Hormones
Table Industry Policy of Peptide Hormones
Table Industry News List of Peptide Hormones
Table Bill of Materials (BOM) of Peptide Hormones
Table Bill of Materials (BOM) Price of Peptide Hormones
Table Labor Cost of Peptide Hormones
Table Depreciation Cost of Peptide Hormones
Table Manufacturing Cost Structure Analysis of Peptide Hormones in 2014
Figure Manufacturing Process Analysis of Peptide Hormones
Table United States Price Analysis of Peptide Hormones 2010-2015 (USD/Dose)
Table United States Cost Analysis of Peptide Hormones 2010-2015 (USD/Dose)
Table United States Gross Analysis of Peptide Hormones 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Peptide Hormones Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Peptide Hormones Manufacturers in 2014
Table RandD Status and Technology Source of United States Peptide Hormones Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Peptide Hormones Key Manufacturers in 2014
Table United States Production of Peptide Hormones by Regions 2010-2015 (Doses)
Table United States Production Market Share of Peptide Hormones by Regions 2010-2015
Figure United States Production Market Share of Peptide Hormones by Regions in 2014
Figure United States Production Market Share of Peptide Hormones by Regions in 2015
Table United States Production of Peptide Hormones by Types in 2010-2015 (Doses)
Table United States Production Market Share of Peptide Hormones by Type in 2010-2015
Figure United States Production Market Share of Peptide Hormones by Type in 2014
Figure United States Production Market Share of Peptide Hormones by Type in 2015
Table United States Sales of Peptide Hormones by Applications 2010-2015 (Doses)
Table United States Production Market Share of Peptide Hormones by Applications 2010-2015
Figure United States Production Market Share of Peptide Hormones by Applications in 2014
Figure United States Production Market Share of Peptide Hormones by Applications in 2015
Table Price Comparison of United States Peptide Hormones Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Peptide Hormones 2010-2015
Table United States Consumption Volume of Peptide Hormones by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Peptide Hormones by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Peptide Hormones by Regions in 2014
Figure United States Consumption Volume Market Share of Peptide Hormones by Regions in 2015
Table United States Consumption Value of Peptide Hormones by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Peptide Hormones by Regions 2010-2015
Figure United States Consumption Value Market Share of Peptide Hormones by Regions in 2014
Figure United States Consumption Value Market Share of Peptide Hormones by Regions in 2015
Table Consumption Price of Peptide Hormones by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Peptide Hormones 2010-2015 (Doses)
Table United States Capacity Market Share of Major Peptide Hormones Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Peptide Hormones 2010-2015 (Doses)
Table United States Production Market Share of Major Peptide Hormones Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Peptide Hormones 2010-2015 (Doses)
Table United States Sales Market Share of Major Peptide Hormones Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Peptide Hormones 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Peptide Hormones Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Peptide Hormones 2010-2015
Figure United States Capacity Utilization Rate of Peptide Hormones 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Peptide Hormones 2010-2015
Figure United States Production Market Share of Major Peptide Hormones Manufacturers in 2014
Figure United States Production Market Share of Major Peptide Hormones Manufacturers in 2015
Figure United States Sales Market Share of Major Peptide Hormones Manufacturers in 2014
Figure United States Sales Market Share of Major Peptide Hormones Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Peptide Hormones 2010-2015
Table United States Supply, Consumption and Gap of Peptide Hormones 2010-2015 (Doses)
Table United States Import, Export and Consumption of Peptide Hormones 2010-2015 (Doses)
Table Price of United States Peptide Hormones Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Peptide Hormones Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Peptide Hormones 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Peptide Hormones 2010-2015
Table Abbott laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Abbott laboratories
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott laboratories 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Abbott laboratories 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Abbott laboratories 2010-2015
Table Abbott laboratories Peptide Hormones SWOT Analysis
Table Affymax Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Affymax
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Affymax 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Affymax 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Affymax 2010-2015
Table Affymax Peptide Hormones SWOT Analysis
Table Alcon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Alcon
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alcon 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Alcon 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Alcon 2010-2015
Table Alcon Peptide Hormones SWOT Analysis
Table Alexion Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Alexion Pharmaceuticals
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alexion Pharmaceuticals 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Alexion Pharmaceuticals 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Alexion Pharmaceuticals 2010-2015
Table Alexion Pharmaceuticals Peptide Hormones SWOT Analysis
Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Allergan
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Allergan 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Allergan 2010-2015
Table Allergan Peptide Hormones SWOT Analysis
Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Biogen
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Biogen 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Biogen 2010-2015
Table Biogen Peptide Hormones SWOT Analysis
Table Biotest Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Biotest Pharmaceuticals
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biotest Pharmaceuticals 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Biotest Pharmaceuticals 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Biotest Pharmaceuticals 2010-2015
Table Biotest Pharmaceuticals Peptide Hormones SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Boehringer Ingelheim
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Boehringer Ingelheim 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Boehringer Ingelheim 2010-2015
Table Boehringer Ingelheim Peptide Hormones SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Bristol-Myers Squibb
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Bristol-Myers Squibb 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Bristol-Myers Squibb 2010-2015
Table Bristol-Myers Squibb Peptide Hormones SWOT Analysis
Table Btg International Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Btg International
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Btg International 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Btg International 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Btg International 2010-2015
Table Btg International Peptide Hormones SWOT Analysis
Table Cangene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Cangene
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cangene 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Cangene 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Cangene 2010-2015
Table Cangene Peptide Hormones SWOT Analysis
Table Csl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Csl
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Csl 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Csl 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Csl 2010-2015
Table Csl Peptide Hormones SWOT Analysis
Table Dendreon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Dendreon
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Dendreon 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Dendreon 2010-2015
Table Dendreon Peptide Hormones SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Eisai
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Eisai 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Eisai 2010-2015
Table Eisai Peptide Hormones SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Eli Lilly
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Eli Lilly 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Eli Lilly 2010-2015
Table Eli Lilly Peptide Hormones SWOT Analysis
Table Ferring Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Ferring Pharmaceuticals
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ferring Pharmaceuticals 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Ferring Pharmaceuticals 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Ferring Pharmaceuticals 2010-2015
Table Ferring Pharmaceuticals Peptide Hormones SWOT Analysis
Table Fresenius Kabi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Fresenius Kabi
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Fresenius Kabi 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Fresenius Kabi 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Fresenius Kabi 2010-2015
Table Fresenius Kabi Peptide Hormones SWOT Analysis
Table Glaxosmithkline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Glaxosmithkline
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Glaxosmithkline 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Glaxosmithkline 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Glaxosmithkline 2010-2015
Table Glaxosmithkline Peptide Hormones SWOT Analysis
Table Grifols Biologicals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Grifols Biologicals
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Grifols Biologicals 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Grifols Biologicals 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Grifols Biologicals 2010-2015
Table Grifols Biologicals Peptide Hormones SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Roche
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Peptide Hormones SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Hospira
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Hospira 2010-2015
Table Hospira Peptide Hormones SWOT Analysis
Table Janssen-Cilag Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Janssen-Cilag
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Janssen-Cilag 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Janssen-Cilag 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Janssen-Cilag 2010-2015
Table Janssen-Cilag Peptide Hormones SWOT Analysis
Table Johnson and Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Johnson and Johnson
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson and Johnson 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Johnson and Johnson 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Johnson and Johnson 2010-2015
Table Johnson and Johnson Peptide Hormones SWOT Analysis
Table Kamada Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Kamada
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kamada 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Kamada 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Kamada 2010-2015
Table Kamada Peptide Hormones SWOT Analysis
Table Kedrion Biopharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Peptide Hormones Picture and Specifications of Kedrion Biopharmaceuticals
Table Peptide Hormones Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kedrion Biopharmaceuticals 2010-2015
Figure Peptide Hormones Capacity (Doses), Production (Doses) and Growth Rate of Kedrion Biopharmaceuticals 2010-2015
Figure Peptide Hormones Production (Doses) and United States Market Share of Kedrion Biopharmaceuticals 2010-2015
Table Kedrion Biopharmaceuticals Peptide Hormones SWOT

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Czech Republic: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

Czech Republic: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

  • $ 2161
  • Industry report
  • October 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the Czech Republic. It presents the latest data of the market size and volume, European ...

Croatia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

Croatia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

  • $ 2161
  • Industry report
  • October 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Croatia. It presents the latest data of the market size and volume, European production, ...

Cyprus: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

Cyprus: Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market. Analysis And Forecast To 2020

  • $ 2161
  • Industry report
  • October 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Cyprus. It presents the latest data of the market size and volume, European production, ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry in Malaysia

  • November 2016
    10 pages
  • OTC  

  • Malaysia  

View report >

Pain Relief Industry in the US

  • November 2016
    31 pages
  • Pain Relief  

    Stroke  

  • United States  

View report >

OTC Industry in the US

  • November 2016
    10 pages
  • OTC  

  • United States  

View report >

Otc Markets In The Us

2 months ago

Otc Markets In The Us

2 months ago

Otc Industry In The Us

2 months ago

Otc Industry In The Us

2 months ago

Related Market Segments :

Hormones

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.